Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
    1.
    发明授权
    Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators 有权
    识别特异性激活人T2R受体的苦配体和相关测定法,用于鉴定人类苦味调节剂

    公开(公告)号:US07883856B2

    公开(公告)日:2011-02-08

    申请号:US11766974

    申请日:2007-06-22

    IPC分类号: G01N33/566 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds. Also, the invention relates to the discovery of specific hT2R9 alleles and their disparate activity in functional assays with the same biter ligands. The invention further relates to the use of these T2R receptors in assays for identifying ligands that modulate the activation of these taste receptors by specific bitter ligands and related compounds. These compounds may be used as additives and/or removed from foods, beverages, cosmetics and medicinals in order to modify (block) T2R-associated bitter taste. Also T2R ligands may be used as therapeutics to treat and modulate T2R associated gastrointestinal and metabolic functions as well as treat gastrointestinal and metabolic diseases such as eating disorders, food sensing, food absorption, obesity, diabetes, Crohn's disease, celiac disease, et al.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现。 此外,本发明还涉及特异性hT2R9等位基因的发现及其在具有相同配体配体的功能测定中的不同活性。 本发明还涉及这些T2R受体在用于鉴定通过特定的苦配体和相关化合物调节这些味觉受体的活化的配体的测定中的用途。 这些化合物可以用作添加剂和/或从食品,饮料,化妆品和药物中去除,以便改变(阻断)T2R相关的苦味。 也可以使用T2R配体作为治疗和调节T2R相关胃肠和代谢功能以及治疗胃肠道和代谢疾病如饮食失调,食物感觉,食物吸收,肥胖,糖尿病,克罗恩病,乳糜泻等的治疗剂。

    HUMAN T2R RECEPTORS FOR RANITIDINE, STRYCHNINE AND DENATONIUM AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS
    2.
    发明申请
    HUMAN T2R RECEPTORS FOR RANITIDINE, STRYCHNINE AND DENATONIUM AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS 有权
    人类T2R受体的RANITIDINE,STRYCHNINE和DENATONIUM及相关测定用于鉴定人体双歧杆菌调味剂

    公开(公告)号:US20090087866A1

    公开(公告)日:2009-04-02

    申请号:US12166980

    申请日:2008-07-02

    IPC分类号: G01N33/567

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter ligands, i.e., acetaminophen, ranitidine, strychnine and denatonium. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors and which may be used as additives in foods, beverages and medicinals for modifying (blocking) T2R-associated bitter taste.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味配体即对乙酰氨基酚,雷尼替丁,士的宁和丹那铵的反应的发现。 本发明还涉及这些受体在用于鉴定调节这些味觉受体的活化的配体的测定中的用途,并且其可用作用于改变(阻断)T2R相关苦味的食品,饮料和药物中的添加剂。

    IDENTIFICATION OF BITTER LIGANDS THAT SPECIFICALLY ACTIVATE HUMAN T2R RECEPTORS AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS
    3.
    发明申请
    IDENTIFICATION OF BITTER LIGANDS THAT SPECIFICALLY ACTIVATE HUMAN T2R RECEPTORS AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS 有权
    识别特异性激活人类T2R受体的双键配体和用于鉴定人类叮咬调味剂的相关测定

    公开(公告)号:US20080038739A1

    公开(公告)日:2008-02-14

    申请号:US11766974

    申请日:2007-06-22

    IPC分类号: G01N33/53 C12Q1/02 C12Q1/68

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds. Also, the invention relates to the discovery of specific hT2R9 alleles and their disparate activity in functional assays with the same biter ligands. The invention further relates to the use of these T2R receptors in assays for identifying ligands that modulate the activation of these taste receptors by specific bitter ligands and related compounds. These compounds may be used as additives and/or removed from foods, beverages, cosmetics and medicinals in order to modify (block) T2R-associated bitter taste. Also T2R ligands may be used as therapeutics to treat and modulate T2R associated gastrointestinal and metabolic functions as well as treat gastrointestinal and metabolic diseases such as eating disorders, food sensing, food absorption, obesity, diabetes, Crohn's disease, celiac disease, et al.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现。 此外,本发明还涉及特异性hT2R9等位基因的发现及其在具有相同配体配体的功能测定中的不同活性。 本发明还涉及这些T2R受体在用于鉴定通过特定的苦配体和相关化合物调节这些味觉受体的活化的配体的测定中的用途。 这些化合物可以用作添加剂和/或从食品,饮料,化妆品和药物中去除,以便改变(阻断)T2R相关的苦味。 也可以使用T2R配体作为治疗和调节T2R相关胃肠和代谢功能以及治疗胃肠道和代谢疾病如饮食失调,食物感觉,食物吸收,肥胖,糖尿病,克罗恩病,乳糜泻等的治疗剂。

    Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositions
    4.
    发明授权
    Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositions 有权
    使用苦味受体筛选抵消含绿色内酯的咖啡组合物的苦味的化合物

    公开(公告)号:US08318447B2

    公开(公告)日:2012-11-27

    申请号:US13094974

    申请日:2011-04-27

    IPC分类号: G01N33/567 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds, i.e., chlorogenic lactone compounds that contribute at least partially to the bitter taste of many coffee beverages. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors by chlorogenic lactones and related compounds and which may be used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste. A preferred embodiment is the use of the identified compounds as additives in coffee and coffee-flavored foods, beverages and medicinals.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现,即,至少部分地促成许多咖啡饮料的苦味的绿色内酯化合物。 本发明还涉及这些受体在测定中用于鉴定调节绿色内酯和相关化合物来调节这些味觉受体的活化并可以用作添加剂和/或从食品,饮料和药物中去除的配体的用途,以便 修改(阻断)T2R相关的苦味。 优选的实施方案是使用所鉴定的化合物作为咖啡和咖啡风味食品,饮料和药物中的添加剂。

    Human T2R receptors for ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators
    5.
    发明授权
    Human T2R receptors for ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators 有权
    用于雷尼替丁,士的宁和denatonium的人T2R受体和用于鉴定人类苦味调节剂的相关测定法

    公开(公告)号:US07915003B2

    公开(公告)日:2011-03-29

    申请号:US12166980

    申请日:2008-07-02

    IPC分类号: G01N33/566 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter ligands, i.e., acetaminophen, ranitidine, strychnine and denatonium. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors and which may be used as additives in foods, beverages and medicinals for modifying (blocking) T2R-associated bitter taste.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味配体即对乙酰氨基酚,雷尼替丁,士的宁和丹那铵的反应的发现。 本发明还涉及这些受体在用于鉴定调节这些味觉受体的活化的配体的测定中的用途,并且其可用作用于改变(阻断)T2R相关苦味的食品,饮料和药物中的添加剂。

    Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
    7.
    发明授权
    Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators 有权
    识别特异性激活人T2R受体的苦配体和相关测定法,用于鉴定人类苦味调节剂

    公开(公告)号:US08715946B2

    公开(公告)日:2014-05-06

    申请号:US13019580

    申请日:2011-02-02

    IPC分类号: G01N33/567 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds. Also, the invention relates to the discovery of specific hT2R9 alleles and their disparate activity in functional assays with the same bitter ligands. The invention further relates to the use of these T2R receptors in assays for identifying ligands that modulate the activation of these taste receptors by specific bitter ligands and related compounds. These compounds may be used as additives and/or removed from foods, beverages, cosmetics and medicinals in order to modify (block) T2R-associated bitter taste. Also T2R ligands may be used as therapeutics to treat and modulate T2R associated gastrointestinal and metabolic functions as well as treat gastrointestinal and metabolic diseases such as eating disorders, food sensing, food absorption, obesity, diabetes, Crohn's disease, celiac disease, et al.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现。 此外,本发明涉及特异性hT2R9等位基因的发现及其在具有相同苦味配体的功能测定中的不同活性。 本发明还涉及这些T2R受体在用于鉴定通过特定的苦配体和相关化合物调节这些味觉受体的活化的配体的测定中的用途。 这些化合物可以用作添加剂和/或从食品,饮料,化妆品和药物中去除,以便改变(阻断)T2R相关的苦味。 也可以使用T2R配体作为治疗和调节T2R相关胃肠和代谢功能以及治疗胃肠道和代谢疾病如饮食失调,食物感觉,食物吸收,肥胖,糖尿病,克罗恩病,乳糜泻等的治疗剂。

    Assays which screen for compounds that modulate bitter taste of chlorogenic lactone compounds
    8.
    发明授权
    Assays which screen for compounds that modulate bitter taste of chlorogenic lactone compounds 有权
    测定调节绿色内酯化合物苦味的化合物的筛选

    公开(公告)号:US07939276B2

    公开(公告)日:2011-05-10

    申请号:US11455693

    申请日:2006-06-20

    IPC分类号: G01N33/567 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds, i.e., chlorogenic lactone compounds that contribute at least partially to the bitter taste of many coffee beverages. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors by chlorogenic lactones and related compounds and which may be used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste. A preferred embodiment is the use of the identified compounds as additives in coffee and coffee-flavored foods, beverages and medicinals.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现,即,至少部分地促成许多咖啡饮料的苦味的绿色内酯化合物。 本发明还涉及这些受体在测定中用于鉴定调节绿色内酯和相关化合物来调节这些味觉受体的活化并可以用作添加剂和/或从食品,饮料和药物中去除的配体的用途,以便 修改(阻断)T2R相关的苦味。 优选的实施方案是使用所鉴定的化合物作为咖啡和咖啡风味食品,饮料和药物中的添加剂。

    Human T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulators
    9.
    发明授权
    Human T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulators 有权
    用于对乙酰氨基酚雷尼替丁,士的宁和非离子的人T2R受体和用于鉴定人苦味调节剂的相关测定

    公开(公告)号:US07407765B2

    公开(公告)日:2008-08-05

    申请号:US11339553

    申请日:2006-01-26

    IPC分类号: G01N33/566 C07K14/705

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter ligands, i.e., acetaminophen, ranitidine, strychnine and denatonium. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors and which may be used as additives in foods, beverages and medicinals for modifying (blocking) T2R-associated bitter taste.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味配体即对乙酰氨基酚,雷尼替丁,士的宁和丹那铵的反应的发现。 本发明还涉及这些受体在用于鉴定调节这些味觉受体的活化的配体的测定中的用途,并且其可用作用于改变(阻断)T2R相关苦味的食品,饮料和药物中的添加剂。

    HUMAN T2R RECEPTORS RECOGNIZING A CLASS OF BITTER MOLECULES FROM COFFEE
    10.
    发明申请
    HUMAN T2R RECEPTORS RECOGNIZING A CLASS OF BITTER MOLECULES FROM COFFEE 有权
    人类T2R受体识别来自咖啡的一类双歧杆菌分子

    公开(公告)号:US20110212856A1

    公开(公告)日:2011-09-01

    申请号:US13094974

    申请日:2011-04-27

    IPC分类号: C40B30/04 G01N33/68

    摘要: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds, i.e., chlorogenic lactone compounds that contribute at least partially to the bitter taste of many coffee beverages. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors by chlorogenic lactones and related compounds and which may be used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste. A preferred embodiment is the use of the identified compounds as additives in coffee and coffee-flavored foods, beverages and medicinals.

    摘要翻译: 本发明涉及T2R味觉受体家族中的特定人味受体对特定苦味化合物的反应的发现,即,至少部分地促成许多咖啡饮料的苦味的绿色内酯化合物。 本发明还涉及这些受体在测定中用于鉴定调节绿色内酯和相关化合物来调节这些味觉受体的活化并可以用作添加剂和/或从食品,饮料和药物中去除的配体的用途,以便 修改(阻断)T2R相关的苦味。 优选的实施方案是使用所鉴定的化合物作为咖啡和咖啡风味食品,饮料和药物中的添加剂。